Table 1.
Main characteristics of the surveyed population
| Characteristic | Result | Nº of patients | |
| Median age - years (range) | 28 (6 - 59) | 104 | |
| Gender (%) | 106 | ||
| Male | 51.9% | ||
| Female | 48.1% | ||
| Ethnic background (%) | 105 | ||
| White | 87.6% | ||
| Black | 11.4% | ||
| Disease stage at diagnosis (%) | 105 | ||
| I | 1.0% | 1 | |
| II | 50.5% | 53 | |
| III | 19.0% | 20 | |
| IV | 29.5% | 31 | |
| Hemoglobin concentration at diagnosis (g/dL) | 87 | ||
| Median (range) | 11.9 (7.6 - 16.2) | ||
| B-type symptoms at diagnosis | 105 | ||
| Absent | 24.8% | 26 | |
| Present | 75.2% | 79 | |
| Tumoral size >10 cm at diagnosis | 105 | ||
| Absent | 65.7% | 69 | |
| Present | 34.3% | 36 | |
| Hemoglobin <10 g/dL at diagnosis | 87 | ||
| Absent | 74.7% | 65 | |
| Present | 25.3% | 22 | |
| Time to relapse after initial treatment | 63 | ||
| Relapse ≤ 1 year | 5.7% | 6 | |
| Relapse > 1 year | 56.2% | 57 | |
| Number of CD34 cells obtained | |||
| Median | 2.6 (0.2 - 10.8) | ||